Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer-Reference-Cited by-同舟云学术

Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer

Published:2022-01 Issue:1 Volume:9 Page:69-74
ISSN:2214-3882
Container-title:Asian Journal of Urology
language:en
Short-container-title:Asian Journal of Urology

Author:

Babst Christa,Amiel Thomas,Maurer Tobias,Knipper Sophie,Lunger Lukas,Tauber Robert,Retz Margitta,Herkommer Kathleen,Eiber Matthias,von Amsberg Gunhild,Graefen Markus,Gschwend Juergen,Steuber Thomas,Heck Matthias

Publisher

Elsevier BV

Reference23 articles.

1. EAU guidelines on prostate cancer Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer;Heidenreich;Eur Urol,2014

2. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer;Sweeney;N Engl J Med,2015

3. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): Survival results from an adaptive, multiarm, multistage, platform randomised controlled trial;James;Lancet,2016

4. Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment;Tzelepi;J Clin Oncol,2011

5. The evolutionary history of lethal metastatic prostate cancer;Gundem;Nature,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of primary cancer in metastatic hormone-sensitive prostate cancer;Current Opinion in Supportive & Palliative Care;2023-10-03

2. Kommentar zu Radikale Prostatektomiebeim oligometastasierten Prostatakarzinom;Aktuelle Urologie;2023-08

3. An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer;Current Oncology;2023-02-10

4. Cytoreductive radical prostatectomy: who benefits from the surgical approach?;Current Opinion in Urology;2023-01-12

5. Zytoreduktive Prostatektomie und Metastasektomie beim metastasierten Prostatakarzinom;Metastasiertes Prostatakarzinom;2023